Corient Private Wealth LLC Trims Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Corient Private Wealth LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 4.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 187,517 shares of the medical equipment provider’s stock after selling 8,087 shares during the quarter. Corient Private Wealth LLC’s holdings in Intuitive Surgical were worth $97,875,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of ISRG. Bennett Selby Investments LP lifted its position in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after acquiring an additional 17 shares in the last quarter. Onefund LLC raised its stake in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC lifted its holdings in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. boosted its stake in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC grew its holdings in Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after buying an additional 19 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Piper Sandler restated an “overweight” rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Leerink Partners increased their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Evercore ISI raised their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Truist Financial upped their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Check Out Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Stock Up 1.6 %

ISRG opened at $484.44 on Monday. The business has a fifty day moving average of $567.46 and a 200 day moving average of $531.94. The stock has a market cap of $172.55 billion, a P/E ratio of 75.58, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.